Month: July 2024

CANTON, Mass., July 15, 2024 (GLOBE NEWSWIRE) —  Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that second quarter of fiscal year 2024 financial results will be reported after the market closes on Thursday, August 8th. Management will host a conference call at 5:00 p.m. Eastern Time on August 8th to discuss the results of the quarter and provide a corporate update with a question and answer session. Those who would like to participate may access the live webcast here, or dial (800) 715-9871 and provide access code 6679912. The live webcast can also be accessed via the company’s website at investors.organogenesis.com. The...

LONG BEACH, Calif. and TORONTO, July 15, 2024 (GLOBE NEWSWIRE) — Glass House Brands Inc. (“Glass House” or the “Company”) (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF), one of the fastest-growing, vertically integrated cannabis companies in the U.S., announced today the reappointment of Hector De La Torre to the Company’s Board of Directors. Mr. De La Torre previously served as an original member of the Board until 2023, when he stepped down due to time restraints connected to other commitments. “We are excited to welcome Hector back to the Glass House Board,” said Kyle Kazan, Co-Founder, Chairman and CEO of Glass House. “Hector made many valuable contributions to our company during his first tenure and was one of the earliest vocal advocates for cannabis policy reform...

Information relative au nombre total de droits de vote et d’actions composant le capital social au 15 juillet 2024 Information relating to the total number of voting rights and shares making up the share capitalAt July 15, 2024 Articles L 233-8 II du Code de commerce et 223-16 du Règlement général de l’Autorité des marchés financiers Articles L 233-8 II of the French Commercial Code and 223-16 of the AMF General Regulations Place de cotation : NYSE Euronext-Paris Compartiment : Eurolist BCode ISIN : FR0014003FE9Date d’arrêté des informations   Declaration date Nombre total d’actions composant le capital social   Total number of shares in the share capital   Nombre total de droits de vote     Total number of voting rights5 juillet 2024July 5, 2024 100 708 785 Nombre théorique des droits de vote (1)Number of theoretical voting rights(1)102 016...

GREENWICH, Conn., July 15, 2024 (GLOBE NEWSWIRE) —  GAMCO Investors, Inc. (“GAMCO”) (OTCQX: GAMI) announced today that its Chairman and co-CEO, Mr. Mario J. Gabelli, has elected to waive all of his Portfolio and Relationship compensation that he would otherwise have been entitled to for the period from August 1, 2024 to October 31, 2024. This waiver does not include his Incentive Management Fee. About GAMCO Investors, Inc. GAMI is known for its research-driven value approach to equity investing (known as PMV with a CatalystTM). GAMI conducts its investment advisory business principally through two subsidiaries: Gabelli Funds, LLC (24 open-end funds, 14 closed-end funds, 5 actively managed semi-transparent ETFs, and a SICAV) and GAMCO Asset Management Inc. (approximately 1,400 institutional and private wealth separate accounts,...